抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Concizumab
All
TD-HY403026_1.jpg
TD-HY403026_2.jpg
TD-HY403026_3.jpg
- Catalog： TD-HY403026
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： Anti-TFPI,NN7415,mab2021,CAS:1312299-39-0
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Concizumab
| Catalog No. | TD-HY403026 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG4-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | Extrinsic pathway inhibitor, Lipoprotein-associated coagulation inhibitor, TFPI, EPI, LACI, TFPI1, Tissue factor pathway inhibitor |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P10646 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | Anti-TFPI,NN7415,mab2021,CAS:1312299-39-0 |
| Background | Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SDS-PAGE for Research Grade Concizumab. |
|
|
SEC-HPLC detection for Research Grade Concizumab. |
|
|
Detects TFPI in indirect ELISAs. |